Grandfield & Dodd, LLC Astrazeneca PLC Transaction History

Grandfield & Dodd, LLC

$1.58 Billion
Q3 2024

A detailed history of Grandfield & Dodd, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 7,426 shares of AZN stock, worth $487,368. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,426

Previous 8,881 16.38%

Holding current value

$487,368

Previous $692,000 16.47%

% of portfolio

0.04%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$76.67 - $87.62 $111,554 - $127,487	-1,455 Reduced 16.38%	7,426 $578,000
Q2 2024 Aug 09, 2024	SELL	$66.81 - $80.83 $22,114 - $26,754	-331 Reduced 3.59%	8,881 $692,000
Q1 2024 May 03, 2024	SELL	$61.03 - $69.57 $34,787 - $39,654	-570 Reduced 5.83%	9,212 $624,000
Q4 2023 Jan 31, 2024	SELL	$61.89 - $69.28 $65,293 - $73,090	-1,055 Reduced 9.74%	9,782 $658,000
Q3 2023 Oct 25, 2023	SELL	$64.85 - $71.7 $56,354 - $62,307	-869 Reduced 7.42%	10,837 $733,000
Q2 2023 Aug 07, 2023	SELL	$69.91 - $75.81 $53,760 - $58,297	-769 Reduced 6.16%	11,706 $837,000
Q1 2023 Apr 28, 2023	SELL	$63.15 - $71.6 $11,935 - $13,532	-189 Reduced 1.49%	12,475 $865,000
Q4 2022 Jan 20, 2023	SELL	$54.21 - $70.44 $54 - $70	-1 Reduced 0.01%	12,664 $0
Q3 2022 Nov 03, 2022	SELL	$53.02 - $135.75 $26,138 - $66,924	-493 Reduced 3.75%	12,665 $690,000
Q1 2022 Apr 19, 2022	SELL	$55.72 - $67.12 $22,232 - $26,780	-399 Reduced 2.94%	13,158 $870,000
Q4 2021 Feb 08, 2022	SELL	$54.02 - $63.83 $38,516 - $45,510	-713 Reduced 5.0%	13,557 $790,000
Q3 2021 Oct 28, 2021	BUY	$55.56 - $60.79 $792,841 - $867,473	14,270 New	14,270 $860,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.

Account

Grandfield & Dodd, LLC Astrazeneca PLC Transaction History